UNSPSC 51352001: Demegestone

This classification denotes a therapeutic progestin with the molecular formula C21H28O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6E89AM91SZ, chemically known as 19-norpregna-4,9-diene-3,20-dione, 17-methyl- (8ci)(9ci) but generally known as demegestone, which bears US NIH Compound Identifier 93057. European Medicines Agency schedules Demegestone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06966MIG.

UNSPSC 51352001 Demegestone is a Commodity code for pharmaceutical products. State and local governments are buying generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing agreements, with solicitations targeting manufacturers and distributors who can supply standardized product lines across participating jurisdictions. The work involves supplying pharmaceuticals with specific National Drug Codes, managing product information systems, maintaining compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act, and establishing pricing relationships with authorized wholesale distributors. Issuing bodies are typically state health and purchasing departments administering multistate cooperative purchasing cooperatives and their member agencies, including state facilities, local government entities, and participating healthcare systems.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities in Minnesota and Oregon. The solicitation requires vendors to maintain contractual relationships with at least two of three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health, and Morris & Dickson Co., LLC), certify cGMP and DSCSA compliance, maintain insurance including $5 million commercial general liability coverage, and submit pricing in one of several formats—flat price, net price, or WAC-minus structures. Evaluation criteria weight price competitiveness at 75 percent, with administrative and EDI capability requirements comprising the remainder. The contract term is two years for new vendors with optional extensions; incumbent amendments align through June 30, 2028, with awarded vendors effective July 1, 2026.